The role of imaging in suspected prostate cancer

European Urological Review

Volumn 6, Issue 2, 2011, Pages 124-127

  Ouzzane, Adil ^a   Villers, Arnauld ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Biopsy; Cancer diagnosis; Focal therapy; Imaging techniques; Magnetic resonance imaging; Observation; Prostatic neoplasm; Ultrasound

Indexed keywords

EID: 84871823988     PISSN: 17583829     EISSN: 1758406X     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, et al., Cancer statistics, 2008, CA Cancer J Clin, 2008;58:71-96.
2. Bouye S, Potiron E, Puech P, et al., Transition zone and anterior stromal prostate cancers: zone of origin and intraprostatic patterns of spread at histopathology, Prostate, 2009;69:105-13.
3. Haffner J, Potiron E, Bouye S, et al., Peripheral zone prostate cancers: location and intraprostatic patterns of spread at histopathology, Prostate, 2009;69:276-82.
4. Mazaheri Y, Shukla-Dave A, Hricak H, et al., Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging - correlation with pathologic findings, Radiology, 2008;246:480-8.
5. Kim Y, Hsu IC, Lessard E, et al., Class solution in inverse planned HDR prostate brachytherapy for dose escalation of DIL defined by combined MRI/MRSI, Radiother Oncol, 2008;88:148-55.
6. Kumar R, Nayyar R, Kumar V, et al., Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/mL: a follow-up study, Urology, 2008;72:859-63.
7. deSouza NM, Riches SF, Vanas NJ, et al., Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer, Clin Radiol, 2008;63:774-82.
8. Toi A, Neill MG, Lockwood GA, et al., The continuing importance of transrectal ultrasound identification of prostatic lesions, J Urol, 2007;177:516-20.
9. Baumann M, Mozer P, Daanen V, Troccaz J. Towards 3D ultrasound image based soft tissue tracking: a transrectal ultrasound prostate image alignment system, Med Image Comput Comput Assist Interv, 2007;10:26-33.
10. Kuligowska E, Barish MA, Fenlon HM, Blake M, Predictors of prostate carcinoma: accuracy of gray-scale and color Doppler US and serum markers, Radiology, 2001;220:757-64.
11. Loch T, Computerized transrectal ultrasound (C-TRUS) of the prostate: detection of cancer in patients with multiple negative systematic random biopsies, World J Urol, 2007;25:375-80.
12. Grabski B, Baeurle L, Loch A, et al., Computerized transrectal ultrasound of the prostate in a multicenter setup (C-TRUS-MS): detection of cancer after multiple negative systematic random and in primary biopsies, World J Urol, 2011; in press.
13. Walz J, Marcy M, Pianna JT, et al., Identification of the prostate cancer index lesion by real-time elastography: considerations for focal therapy of prostate cancer, World J Urol, 2011; in press.
14. Mitterberger MJ, Aigner F, Horninger W, et al., Comparative efficiency of contrast-enhanced colour Doppler ultrasound targeted versus systematic biopsy for prostate cancer detection, Eur Radiol, 2010;20:2791-6.
15. Taverna G, Morandi G, Seveso M, et al., Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling, BJU Int, 2011; in press.
16. Dickinson L, Ahmed HU, Allen C, et al., Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting, Eur Urol, 2011;59:477-94.
17. Delongchamps NB, Rouanne M, Flam T, et al., Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging, BJU Int, 2011;107:1411-18.
18. Ouzzane A, Puech P, Lemaitre L, et al., Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging and grading, Urology, 2011; in press.
19. Hambrock T, Somford DM, Hoeks C, et al., Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen, J Urol, 2010;183:520-7.
20. Tan JS, Thng CH, Tan PH, et al., Local experience of endorectal magnetic resonance imaging of prostate with correlation to radical prostatectomy specimens, Ann Acad Med Singapore, 2008;37:40-4.
21. Jung DC, Lee HJ, Kim SH, et al., Preoperative MR imaging in the evaluation of seminal vesicle invasion in prostate cancer: pattern analysis of seminal vesicle lesions, J Magn Reson Imaging, 2008;28:144-50.
22. Yoshimitsu K, Kiyoshima K, Irie H, et al., Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: correlation with stepwise histopathology, J Magn Reson Imaging, 2008;27:132-9.
23. Langer DL, van der Kwast TH, Evans AJ, et al., Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2-sparse versus dense cancers, Radiology, 2008;249:900-8.
24. Gibbs P, Liney GP, Pickles MD, et al., Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla, Invest Radiol, 2009;44:572-6.
25. Hambrock T, Somford DM, Huisman HJ, et al., Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer, Radiology, 2011;259:453-61.
26. Girouin N, Mege-Lechevallier F, Tonina Senes A, et al., Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable?, Eur Radiol, 2007;17:1498-509.
27. Klotz L, Active surveillance with selective delayed intervention: using natural history to guide treatment in good risk prostate cancer, J Urol, 2004;172:S48-50;discussion S50-1.
28. Fuchsjäger M, Shukla-Dave A, Akin O, et al., Prostate Cancer Imaging, Acta Radiologica 2008;49(1):107-20.
29. Haffner J, Lemaitre L, Puech P, et al., Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection, BJU Int, 2011; in press.